Weiskittel, T., Koukol, A., Kellinger, C., Ugolkov, A., Seifarth, C., Li, H., Mahalingam, D., Zhang, L., Carneiro, B. A., El-Deiry, W. S., Mazar, A. P. (2025). Machine learning and statistical prediction of overall survival (OS) from pre-dose plasma biomarkers in a randomized phase 2 trial (1801 Part 3B) of the GSK-3 inhibitor elraglusib in metastatic pancreatic ductal adenocarcinoma (mPDAC): Application toward patient enrichment.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.4185